Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Thu, 05.11.2026
HelloFresh SE
Q3 2026: HelloFresh SE advances profitabilityacross product segments
HelloFresh Group achieved constant currency revenue of approx. €1.4 billion in Q3 2026 (Q3 2025: €1.6 billion, -11.3% y-o-y)
Average Order Value (“AOV”) increased by 7.5% y-o-y in constant currency to €70.5 in Q3 2026 (Q3 2025: €65.6), driven by selective price increases, hig [ … ]
Thu, 05.11.2026
Commerzbank Aktiengesellschaft
Operating result after 9M increased by 17% to a new record high of €4bn – in Q3 up 25% to €1.3bn year-on-year
9M net result raised by 41% to a record €2.7bn and by 45% to €859m in Q3
Revenues after 9M increased by 8% to €9.7bn – up 9% to €3.2bn in Q3
Net commission income after 9M up by around 8% to €3.2bn, driven by strong securities business – [ … ]
Thu, 05.11.2026
Andamanda Phuket
EQS Newswire / 05/11/2026 / 04:00 CET/CEST
36 slide lanes, family splash zones and time to unwind at The Great Water Kingdom, with internationally trained lifeguards and recognition from Trip.com and Tripadvisor.
PHUKET, THAILAND - Media OutReach Newswire - 5 November 2026 - One wants a quiet morning by the sea, another wants to explore hist [ … ]
Thu, 05.11.2026
AlphaESS
NANTONG, China, Nov. 5, 2026 /PRNewswire/ -- AlphaESS has once again been recognized as a Tier 1 global energy storage manufacturer by BloombergNEF (BNEF) in its Q4 2026 list, reaffirming its established track record in energy storage projects and growing presence in the global utility-scale market.
T [ … ]
Wed, 04.11.2026
Menarini Industrie Farmaceutiche Riunite
First clinical data for dapolsertib monotherapy: initial results from the Phase II JASPIS-01 study of dapolsertib (MEN1703), a first-in-class oral dual PIM/FLT3 kinase inhibitor, in patients with relapsed/refractory (r/r) aggressive B-cell non-Hodgkin lymphoma (B-NHL) who have exhausted available standard treatment options.
Clinical activity obse [ … ]
Wed, 04.11.2026
Redis
SAN FRANCISCO, Nov. 4, 2026 /PRNewswire/ -- Redis today announced the next chapter of Redis Iris, its real-time context engine for AI agents. Redis Iris now offers six customizable capabilities designed to be used together or independently, that give agents the memory, context, and messaging they need to work reliably in the real world: Redis Inten [ … ]
Wed, 04.11.2026
Taiwan Stock Exchange Corporation
Event Brings Together More Than 400 Participants as Taiwan Advances Its Asian Asset Management Center Initiative
TAIPEI, Nov. 4, 2026 /PRNewswire/ -- Taiwan launched its second annual "Taiwan Weeks" on Tuesday to strengthen global capital market connections and advance its ambition to become a leading asset management center in Asia.
[ … ]
Wed, 04.11.2026
Synopsys, Inc.
Supporting the European Chips Act, startups and research teams will gain access to Synopsys chip design solutions to advance Europe's strategic goals in areas such as AI and high-performance computing (HPC)
Highlights
Simplified access to Synopsys' advanced EDA design software through the EuroCDP
Support covers both Level 1 and Level 2 of the EuroC [ … ]
Wed, 04.11.2026
Segway Powersports
MILAN, Nov. 4, 2026 /PRNewswire/ -- Segway Powersports unveiled its Model Year 2027 (MY27) lineup and next-generation iFUN 2.0 connected system at EICMA 2026. Alongside upgraded ATVs, a flagship two-row UTV and new connected technologies, the company outlined plans to expand its global dealer and service networks.
AT6 Pro: More Power, Sharper Cont [ … ]
Wed, 04.11.2026
DeFi Technologies Inc.
TORONTO, Nov. 4, 2026 /PRNewswire/ -- DeFi Technologies Inc. (the "Company" or "DeFi Technologies") (Nasdaq: DEFT) (CBOE CA: DEFI) (GR: R9B), a financial technology company bridging the gap between traditional capital markets and decentralized finance ("DeFi"), today announces it will conduct a shareholder call on Friday, November 13, 2026 at 11:00 [ … ]
